PMID- 17883937 OWN - NLM STAT- MEDLINE DCOM- 20081118 LR - 20070921 IS - 1671-4083 (Print) IS - 1671-4083 (Linking) VI - 28 IP - 10 DP - 2007 Oct TI - 5-Hydroxydecanoate inhibits proliferation of hypoxic human pulmonary artery smooth muscle cells by blocking mitochondrial K(ATP) channels. PG - 1531-40 AB - AIM: To study the effect of 5-hydroxydecanoate (5-HD) on the proliferation of 24 h hypoxic human pulmonary artery smooth muscle cells (HPASMC) and to explore the pharmacological mechanisms of 5-HD as an inhibitor of mitochondrial membrane ATP-sensitive potassium channel activation. METHODS: Normoxic or hypoxic HPASMC in culture were stimulated by either diazoxide or 5-HD for 24 h. The proliferation of HPASMC was examined by 3- (4,5-dimethyl-2-thiazol-yl) -2,5-diphenyl- 2H-tetrazolium bromide (MTT) assay and proliferating cell nuclear antigen (PCNA) immunohistochemistry staining. The apoptosis of HPASMC was assessed by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay and flow cytometric analysis. The relative changes in mitochondrial membrane potential (deltaPhi(m)) were measured using the rhodamine fluorescence (R-123) technique. RESULTS: Both hypoxia and diazoxide stimulation increased deltaPhi(m) value measured by the absorbance of MTT, PCNA-positive staining and decreased TUNEL-positive staining and apoptotic cells in HPASMC. Hypoxia and the concomitant stimulation of diazoxide obviously enhanced the effects of hypoxia or diazoxide alone. 5-HD significantly attenuated the effects in each of the above conditions. Additionally, 5-HD partially inhibited the effect of hypoxia on R-123 fluorescence intensity in HPASMC. CONCLUSION: 5-HD can inhibit the proliferation of hypoxic HPASMC by blocking mitochondrial K(ATP) channels. FAU - Wang, Tao AU - Wang T AD - Department of Respiratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. wt7636@sina.com.cn FAU - Zhang, Zhen-Xiang AU - Zhang ZX FAU - Xu, Yong-Jian AU - Xu YJ FAU - Hu, Qing-Hua AU - Hu QH LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Acta Pharmacol Sin JT - Acta pharmacologica Sinica JID - 100956087 RN - 0 (Decanoic Acids) RN - 0 (Hydroxy Acids) RN - 0 (Potassium Channel Blockers) RN - 0 (Potassium Channels) RN - 0 (Proliferating Cell Nuclear Antigen) RN - 0 (mitochondrial K(ATP) channel) RN - 624-00-0 (5-hydroxydecanoic acid) SB - IM MH - Apoptosis/drug effects MH - Cell Hypoxia MH - Cell Proliferation/*drug effects MH - Cells, Cultured MH - Decanoic Acids/*pharmacology MH - Humans MH - Hydroxy Acids/*pharmacology MH - Membrane Potential, Mitochondrial/drug effects MH - Muscle, Smooth, Vascular/cytology/drug effects/metabolism MH - Myocytes, Smooth Muscle/cytology/*drug effects/metabolism MH - Potassium Channel Blockers/pharmacology MH - Potassium Channels/metabolism/*physiology MH - Proliferating Cell Nuclear Antigen/metabolism MH - Pulmonary Artery/cytology EDAT- 2007/09/22 09:00 MHDA- 2008/11/19 09:00 CRDT- 2007/09/22 09:00 PHST- 2007/09/22 09:00 [pubmed] PHST- 2008/11/19 09:00 [medline] PHST- 2007/09/22 09:00 [entrez] AID - 10.1111/j.1745-7254.2007.00636.x [doi] PST - ppublish SO - Acta Pharmacol Sin. 2007 Oct;28(10):1531-40. doi: 10.1111/j.1745-7254.2007.00636.x.